The Supreme Court case that could slow generic drugs
An Arm and a Leg
An Arm and a Leg
4.8 • 1.1K Ratings
🗓️ 27 April 2026
⏱️ 21 minutes
🧾️ Download transcript
Summary
It’s a case you’ve (probably) never heard of: This week, the Supreme Court is hearing oral arguments in Hikma v. Amarin — a legal battle that could impact how much you ultimately pay for prescription drugs.
Here’s why the case matters: As soon as a generic version of a brand-name drug comes to market, its price typically drops by half. Within 10 years, by more than 75%. Meaning: the sooner we have access to generics, the less we pay at the pharmacy counter.
But one of the fastest legal pathways for generic companies to get their drugs to market may be about to get a lot narrower – depending on how the court rules later this year.
Amarin, a brand-name drugmaker, has accused Hikma, a generic company, of encouraging doctors to infringe on their patent for a drug called Vascepa.
The case revolves around the legal concept of skinny labels: a carveout in drug patent law that allows generic companies to bring drugs to market when one of the brand-name drug’s patents has expired, but others haven’t.
And it raises the (unexpected) question of whether it’s OK for a generic drug company to call their product the generic version of something.
Legal experts help us unpack the nerdy details – including how this case came to be, and what’s at stake for both generic drug companies and anyone looking forward to one day paying less for an expensive brand-name drug.
Want to learn how these drug monopolies work – and came to be in the first place? Check out our previous episode: Why drugs cost so much, 101: Medicine monopolies
Here's a copy of this episode's transcript.
Send your stories and questions. Or call 724 ARM-N-LEG.
And of course we’d love for you to support this show.
See omnystudio.com/listener for privacy information.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Join KUOW in celebrating public media this May, beginning with Public Media Giving Days, |
| 0:05.7 | coming up May 1st and 2nd. |
| 0:07.5 | Public Media Giving Days are a national effort to strengthen public media. |
| 0:11.4 | Across the country, listeners like you give to power local news and stronger communities. |
| 0:16.3 | Be one of the first to step up and support your local station. |
| 0:19.4 | Give now at KUOW.org or the KUOWF. And thank you. |
| 0:24.7 | You know, every day on Up First, NPR's Golden Globe nominated morning news podcast, we bring you three |
| 0:30.4 | essential stories. At the heart of each story are questions. What really happened? What really |
| 0:36.6 | mattered? What happens next? At NPR, we stand for |
| 0:39.9 | your right to be curious and to follow the facts. Follow up first wherever you get your podcasts |
| 0:45.6 | and start your day knowing what matters and why. |
| 0:48.5 | Hey there. Dr. Anmel Gupta is a resident physician at the University of Michigan. |
| 0:58.3 | One day a week, he drives 30 miles north of Ann Arbor to a rural clinic. |
| 1:03.2 | And for a lot of his patients there, that's the only doctor they can get to within an hour. |
| 1:07.2 | They have to travel the furthest. They're often the ones that are uninsured or on Medicaid. |
| 1:13.5 | They often are coming and seeking care later than when you wish they had access to care. |
| 1:21.4 | So they're sicker. And the cost of prescription drugs comes up in like every single visit. |
| 1:26.5 | And I'm meeting patients who are just now being able to afford these medications who maybe weren't able to, five, ten years ago, |
| 1:28.5 | who needed it then. |
| 1:29.6 | Take statins, those drugs that lower cholesterol. |
| 1:32.4 | One of the most popular brand name versions, Crestor, finally went generic in 2016. |
| 1:37.8 | But before that, a lot of patients like Dr. Gupta's simply couldn't afford it. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from An Arm and a Leg, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of An Arm and a Leg and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

